 |
Asia's largest influenza industry gathering
Overview
Influenza Congress brings together flu vaccine producers from all across Asia and globally to uncover best business strategies to gain in-roads and success in Asia's influenza market.
To stay abreast of the latest industry research, partner with key stakeholders or learn how the leading vaccine companies are managing their bottom-lines, come to Influenza Congress Asia.
Who exhibits
- Bioprocess equipment
- Cell Culture
- CRO
- CMO
- Adjuvants
- Drug Delivery
- Facility Design
- Biotechs
- Supply Chain & Logistics
- Platform Technology
- Consultants
Reasons to exhibit
Your customers are here to:
- Discover new technologies in viral forecasting, manufacturing and stockpiling
- Gain knowledge about the changing regulatory landscape for influenza vaccines in Asia
- Learn how to improve vaccine effectiveness, efficiency and safety and the growing inclusion of adjuvants
- Stay abreast of the latest flu vaccine trends from regulators, biotechs, and the research community
Who attends
- Head of Vaccines
- Head of Infectious Diseases
- Head of Clinical Development
- Head of Manufacturing
- Head of R&D
- Head of Business Development
- Head of Licensing
- Head of Pandemic Control
- Head of Medical Affairs
- Head of Immunisation
- Head of Surveillance
- Head of Regulatory Affairs
- Head of Cell Culture
- Head of Production
- Head of Biologics
From pharmaceutical companies, biotech companies, research institutes, CDCs/regulators, NGOs and government.
Testimonials
"The WVC is a nice way of engaging many different areas of experts in different areas. It is also good to understand the current frontiers that everyone is facing and build collaboration. It is a good platform to build foundations for partnerships"
Bing Yan, Pfizer, China
I'm interested in speaking at the World Influenza Congress 2013 ›
